we evaluated the hemodynamic effects of hydralazine , 50 mg , administered orally every 6 hours for 48 hours in 14 patients with right ventricular failure and pulmonary hypertension resulting from various causes .
C0020223
hydralazine
C0020542
pulmonary hypertension